Socinski MA, Jotte RM, Cappuzzo F, Nishio M, et al. Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials. JAMA Oncol 2023 Feb 16. doi: 10.1001/jamaoncol.2022.7711.
PMID: 36795388